StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Santen Pharmaceutical Co., Ltd.
Tokyo Stock Exchange:4536.T
Sector
Location
Market Cap
USD 3.77 B
Share Price
USD 11.08
Avg Daily Volume
1,248,481
Change (1 day)
-1.66%
Change (1 year)
-1.67%
Change (YTD)
7.49%
Santen Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending March 31, 2025: USD 406.15 M
Santen Pharmaceutical Co., Ltd. Operating Cash Flow is USD 406.15 M for the year ending March 31, 2025, a -15.38% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Santen Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending March 31, 2024 was USD 479.99 M, a 71.67% change year over year.
-
Santen Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending March 31, 2023 was USD 279.61 M, a -26.08% change year over year.
-
Santen Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending March 31, 2022 was USD 378.24 M, a 7.93% change year over year.
-
Santen Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending March 31, 2021 was USD 350.44 M, a -5.66% change year over year.
Competitors
Glaukos Corporation
USD 103.81
GKOS
-2.74
-2.57%
PharmaResearch Co., Ltd.
USD 405.60
214450.KQ
-1.12
-0.28%
Bausch Health Companies Inc.
USD 6.41
BHC.TO
-0.24
-3.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Tarsus Pharmaceuticals, Inc.
USD 39.18
TARS
-1.98
-4.81%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Glaukos Corporation
USD 103.81
GKOS
-2.74
-2.57%
PharmaResearch Co., Ltd.
USD 405.60
214450.KQ
-1.12
-0.28%
Bausch Health Companies Inc.
USD 6.41
BHC.TO
-0.24
-3.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Tarsus Pharmaceuticals, Inc.
USD 39.18
TARS
-1.98
-4.81%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%